OBJECTIVE: Data suggest that matrix metalloproteinase-9 (MMP-9) has a role in atherosclerosis. The phagocytic NADPH oxidase has been also associated with atherosclerosis. This study aimed to investigate the association between phagocytic NADPH oxidase and MMP-9 in human atherosclerosis. METHODS AND RESULTS: In vitro experiments performed in human monocytes showed that NADPH oxidase activation enhanced MMP-9 secretion and activity, determined by enzyme-linked immunosorbent assay and zymography, respectively. Immunohistochemical study showed that phagocytic NADPH oxidase localized with MMP-9 in endarterectomies from patients with carotid stenosis. In addition, a positive relationship (P<0.001) was found between phagocytic NADPH oxidase-dependent superoxide production determined with lucigenin and plasma MMP-9 levels in 188 asymptomatic subjects free of overt clinical atherosclerosis. In multivariate analysis, this association remained significant after adjustment for cardiovascular risk factors. Interestingly, subjects in the upper quartile of superoxide production exhibited the highest values of MMP-9, oxidized low-density lipoprotein, nitrotyrosine, carotid intima media thickness, and an increased presence of carotid plaques. CONCLUSIONS: Enhanced NADPH oxidase-dependent *O2(-) production stimulates MMP-9 in monocytes and this relationship may be relevant in the atherosclerotic process. Moreover, MMP-9 emerges as an important mediator of the phagocytic NADPH oxidase-dependent oxidative stress in atherosclerosis.
OBJECTIVE: Data suggest that matrix metalloproteinase-9 (MMP-9) has a role in atherosclerosis. The phagocytic NADPH oxidase has been also associated with atherosclerosis. This study aimed to investigate the association between phagocytic NADPH oxidase and MMP-9 in humanatherosclerosis. METHODS AND RESULTS: In vitro experiments performed in human monocytes showed that NADPH oxidase activation enhanced MMP-9 secretion and activity, determined by enzyme-linked immunosorbent assay and zymography, respectively. Immunohistochemical study showed that phagocytic NADPH oxidase localized with MMP-9 in endarterectomies from patients with carotid stenosis. In addition, a positive relationship (P<0.001) was found between phagocytic NADPH oxidase-dependent superoxide production determined with lucigenin and plasma MMP-9 levels in 188 asymptomatic subjects free of overt clinical atherosclerosis. In multivariate analysis, this association remained significant after adjustment for cardiovascular risk factors. Interestingly, subjects in the upper quartile of superoxide production exhibited the highest values of MMP-9, oxidized low-density lipoprotein, nitrotyrosine, carotid intima media thickness, and an increased presence of carotid plaques. CONCLUSIONS: Enhanced NADPH oxidase-dependent *O2(-) production stimulates MMP-9 in monocytes and this relationship may be relevant in the atherosclerotic process. Moreover, MMP-9 emerges as an important mediator of the phagocytic NADPH oxidase-dependent oxidative stress in atherosclerosis.
Authors: Jean Marie Ruddy; Adam W Akerman; Denise Kimbrough; Elizabeth K Nadeau; Robert E Stroud; Rupak Mukherjee; John S Ikonomidis; Jeffrey A Jones Journal: J Vasc Surg Date: 2016-12-27 Impact factor: 4.268
Authors: Krzysztof Szade; Gunsagar S Gulati; Charles K F Chan; Kevin S Kao; Masanori Miyanishi; Kristopher D Marjon; Rahul Sinha; Benson M George; James Y Chen; Irving L Weissman Journal: Antioxid Redox Signal Date: 2018-01-09 Impact factor: 8.401
Authors: Chen-Shan Chen Woodcock; Yi Huang; Steven R Woodcock; Sonia R Salvatore; Bhupinder Singh; Franca Golin-Bisello; Nancy E Davidson; Carola A Neumann; Bruce A Freeman; Stacy G Wendell Journal: J Biol Chem Date: 2017-11-20 Impact factor: 5.157
Authors: Amie K Lund; JoAnn Lucero; Selitá Lucas; Michael C Madden; Jacob D McDonald; Jean-Clare Seagrave; Travis L Knuckles; Matthew J Campen Journal: Arterioscler Thromb Vasc Biol Date: 2009-01-15 Impact factor: 8.311
Authors: Jordan D Miller; Yi Chu; Robert M Brooks; Wayne E Richenbacher; Ricardo Peña-Silva; Donald D Heistad Journal: J Am Coll Cardiol Date: 2008-09-02 Impact factor: 24.094